Ethical Considerations in the Use of Direct-To-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians
- 1 December 2003
- journal article
- Published by Springer Nature in Journal of Business Ethics
- Vol. 48 (3) , 279-290
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- DTC pharmaceutical advertising: the debate’s not overJournal of Consumer Marketing, 2003
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementBMJ, 2003
- Changing the Status of Drugs from Prescription to Over-the-Counter AvailabilityNew England Journal of Medicine, 2001
- The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United StatesJAMA, 2000
- R&D and Promotion in Pharmaceuticals: A Conceptual Framework and Empirical ExplorationJournal of Marketing Theory and Practice, 2000
- On the Nature and Properties of Appeals Used in Direct-to-Consumer Advertising of Prescription DrugsPsychological Reports, 2000
- The Impact of Pharmaceutical Direct AdvertisingHealth Marketing Quarterly, 1998
- Pharmaceutical Promotions — A Free Lunch?New England Journal of Medicine, 1992
- Pharmaceutical Manufacturers and Self-Regulation of Drug Advertising and PromotionJournal of Drug Issues, 1992